HGF, MET-amplification and EGFR-T790M upregulate PD-L1 expression in NSCLC through different mechanisms, attenuating lymphocyte activation and cytotoxicity in vitro and in vivo, and promoting immune escape of tumor cells (Peng et al., 2019). Here, EGFR is linked to neoplasm.